Pitch Decks
On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel
Reigniting p53
Quintrigen was established after decades of research at the Weizmann Institute of Science. They have a single goal: to get mutant p53 protein back to work and assume its role as Guardian of the Genome. As it turns out, mutation in the p53 protein is involved in about 50% of cancers. By transforming this protein from mutant to normal again, the company expects to impact the lives of millions of cancer patients worldwide.
What did we do?
We wanted to give Quintrigen a good start. So we rewrote their narrative—we showed how reigniting p53 enables it to resume its normal functionality, a change that has the potential to eliminate about half of cancer types. We then created their entire graphical language based on their logo, and built their whole site: inception, structure, content, design, and high-end programming. And because their investors are from South Korea, we made the site bi-lingual. We always want to make sure everyone speaks the same language.
On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel
On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel On the pulse of digital health in Israel
Reigniting p53
Click on the image to scroll the full page
Reigniting p53
Our peptide has the potential to treat half of all cancers. We looked for a way to explain our complex science in language potential investors can understand and relate to. CadenSee jumped right in. They transformed our scientific jargon into simple yet an exciting story. Then, they created a graphical language around our existing logo, and the branding materials. Finally, they designed an interactive bi-lingual website that both we and our Korean investors absolutely love.
You can contact us in multiple ways: By email, filling the form on the right, and LinkedIn. Let's start!